Clinical trialNCT06915025RecruitingPhase 3Interventional

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

SponsorImunonEnrollment500Epithelial Ovarian CancerFallopian Tube CancerOvarian CancerPrimary Peritoneal Carcinoma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Premal H Thaker, M.D.
Washington University School of Medicine
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Advent Health
Orlando, Florida, United States
Robert Holloway, MD
Recruiting
Masonic Cancer Center, University of Minnesota
Minneapolis, Minnesota, United States
Melissa Geller, M.D.
Not, yet, recruiting
Washington University School of Medicine in St. Louis
St Louis, Missouri, United States
Andrea Hagemann, MD
Recruiting
Providence Cancer Institute
Portland, Oregon, United States
Christopher Darus, MD
Recruiting
Sanford Health
Sioux Falls, South Dakota, United States
Maria Bell, MD
Recruiting
Erlanger Health
Chattanooga, Tennessee, United States
Stephen DePasquale, MD
Recruiting
Providence Sacred Heart Medical Center & Children'S Hospital
Spokane, Washington, United States
Melanie Bergman, MD
Recruiting
Froedtert and the Medical College of Wisconsin
Milwaukee, Wisconsin, United States
William Bradley, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 9 Jul 2025
Primary completion: 31 Oct 2032
Completion: 31 Oct 2032
Last update posted: 6 Jul 2026
Registered enrollment: 500
Registry id: NCT06915025

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.